Enhanced Dual-Action Immunotherapy in CAR-T Cells Boosts Control of B-ALL Progression
B-cell acute lymphoblastic leukemia (B-ALL) remains the most prevalent pediatric cancer, representing approximately 85% of all leukemia diagnoses in children. ...
B-cell acute lymphoblastic leukemia (B-ALL) remains the most prevalent pediatric cancer, representing approximately 85% of all leukemia diagnoses in children. ...
Crystal L. Mackall Honored with Prestigious Cancer Immunology Award In a significant milestone for cancer research and treatment, Dr. Crystal ...
New breakthroughs in cancer research have emerged from Memorial Sloan Kettering Cancer Center (MSK), highlighting diverse advancements in the treatment ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine